← Evidence map

ReviewTargeted oncology2024

Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer.

Ahmed Elhariri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39123077